US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares ...
Amgen gets expanded FDA label approval for Uplizna
Amgen ( NASDAQ: NASDAQ: AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label ...
Le Lézard44m
Allurion Announces Postponement of Special Meeting of Stockholders
Allurion Technologies, Inc. ("Allurion" or the "Company") , a company dedicated to ending obesity, today announced that its Special Meeting of Stockholders (the "Special Meeting"), originally ...
Le Lézard1h
Malvina Eydelman, MD, Appointed CEO of Collaborative Community on Ophthalmic Innovation (CCOI)
The Board of Directors of The Collaborative Community on Ophthalmic Innovation is excited to announce the appointment of Malvina Eydelman, MD, as Chief Executive Officer (CEO), effective ...